Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1 | Contract Pharma

What are you searching for?

Sign in
Sponsored Content

Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

A Science-Based Holistic Approach

Released By Lighthouse Instruments

The revised EU Annex 1, published on August 25, 2022, contains new requirements for ensuring the container closure integrity (CCI) of sterile pharmaceutical products, causing pharmaceutical companies to reassess their CCI policies for compliance. Lighthouse Instruments’ experts can support you on these changing requirements in time to be prepared for the new regulations. Click here to learn how.

Watch the Lighthouse Instruments presentation to:

  • Learn in detail how the new requirements of the revised EU Annex 1 may impact your strategy for ensuring CCI of sterile pharmaceutical products.
  • Gain understanding of the advantages and disadvantages of CCI testing methods and why a science-based holistic approach to ensure good CCI is important.
  • Gain understanding of how cold chain storage and transport can impact the CCI of sterile pharmaceutical products.

 

Request more information from Lighthouse Instruments

Request more information from Lighthouse Instruments

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics